Work

Long-term efficacy and safety of obeticholic acid in patients with PBC from the POISE trial grouped biochemically by risk of disease progression

Year: 2021

Type: article

Source: Digestive and Liver Disease

DOI: 10.1016/j.dld.2020.12.049

Authors: C.L. Bowlus, M. Trauner, A. Liberman, E. Malecha, L. MacConell, A.E. Kremer, F. Nevens, A. Floreani

Institutions: University of California, Davis, Medical University of Vienna, Intercept Pharmaceuticals (United States), Friedrich-Alexander-Universität Erlangen-Nürnberg, KU Leuven, University of Padua

Language: English

Topic: Liver Diseases and Immunity

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4242026136

FWCI: 0.118

Cites:

Cited by: 1

Related to: 10